cochrane系统评价的格式

cochrane系统评价的格式内容摘要：

reported if there are any. Any secondary interest (such as personal conflicts) that might unduly influence judgements made in a review (concerning, for example, the inclusion or exclusion of studies, assessments of the validity of included studies or the interpretation of results) should be reported. 评论者可以报道一些影响他们判断的利益冲突，包括个人的、政 治的、学术的和其他可能的冲突，也可以是经济上的冲突。 如果一个人对某 一主题一概不知并且没有法律规定的利益冲突，那么可能会将其取消。 经济利益上的冲突应该引起更大的关注，应该而且必须避免，但是如果出现应随时提出。 一些可能影响判断力的次级冲突也应该被提出来 (例如研究的相容性和排斥性，评价研究或者译文的有效性 )。 （在“利益冲突”标题下，评价者应报告任何可能影响他们判断的利益冲突，包括来自个人、政 治、学术和其他可能的冲突以及经济冲突。 而偏好（兴趣）冲突是不可避免的，因为只有当对某主题一无所知的人才会对该主题没有任何的偏好（兴趣）导向。 （ Smith 1994) 经济利益冲突最受 人关注，是能够并应该避免的，一旦存在，则必须在报告中予以透露。 任何可能过度影响评价过程中判断（如研究的纳入与排除，纳入研究真实性的评估或结果的解释）的次要利益（如个人冲突）都应予以说明。 ） Disclosing a conflict of interest does not necessarily reduce the worth of a review and it does not imply dishonesty. However, conflicts of interest can influence judgements in subtle ways. Reviewers should let the editors of their Collaborative Review Group know of potential conflicts even when they are confident that their judgements were not or will not be influenced. Editors may decide that disclosure is not warranted or they may decide that readers should know about such a conflict of interest so that they can make up their own minds about how important it is. Decisions about whether or not to publish such information should be made jointly by reviewers and editors. 披露利益冲突并没有降低综述的价值，并不反映综述的不真实性。 但是利益冲突可以影响判断力。 即使他们自信他们的判断力并没有受到影响，评论者也应该让编辑人员了解潜在的冲突。 编辑人员有责任让读者了解利益冲突以便引起足够的重视，是否公开这一信息则是由评论者和编辑人员决定。 （披露利益冲突并不一定会降低评价的价值，也并不意味着不诚实。 但利益冲突可能以很微妙的方式影响评价者的判断。 即使评价者坚信自己的判断力不会受影响，也应让 CRG 的编辑们知晓潜在的冲突。 编辑可以作出该利益冲突不值得暴光的决定，或是作出应让读者 知道并由他们自己去判断该冲突重要性的决定。 但最后是否发表该信息要由评价者和编辑共同决定。 ） To help ensure the integrity and perceived integrity of Cochrane Reviews, all reviewers must sign the relevant statements in the form giving the Cochrane Collaboration permission to publish their review in addition to disclosing conflicts of interest. 为了保证综述的一致性，除公开出版物以外评论者必需按照委员会规定的格式进行书写。 （为保证 COCHRANE 系统评价的公正性和完整性，除应暴光利益冲突外，所有的评价者还必须按规定格式签署相关声明，并同意 COCHRANE 协作网发表他们的系统评价。 ） Publication of Cochrane Reviews in print journals and books 杂志或者图书中出版的综述（以杂志和书籍形式出版 COCHRANE 系统评价） Reviewers may wish to seek copublication of Cochrane Reviews in peerreviewed medical journals, particularly in those journals that have expressed enthusiasm for copublication of Cochrane Reviews. For the Cochrane Collaboration, there is one essential condition of copublication: Cochrane Reviews must remain free for dissemination in any and all media, without restriction from any of them. To ensure this, Cochrane reviewers grant the Collaboration worldwide licences for these activities, and do not sign over exclusive copyright to any journal or other publisher. A journal is free to request a nonexclusive copyright that permits it to publish and republish a review, but this cannot restrict the publication of the review by the Cochrane Collaboration in whatever form the Collaboration feels appropriate. 评论者热衷于寻找医学杂志中特别是那些向 cochrane 综述表示合作意向的杂志。 这种合作中的关键因素是： cochrane 评论者必须不受制于其合作杂志，为自由之身。 为了保证这一点，cochrane 评论者必须拥有世界范围内的营业许可证，并且不在其他杂志出版权上签字。 （ COCHRANE 评价者可能希望寻求有同行审稿的医学杂志共同出版 COCHRANE 系统评价，尤其是对共同发表 COCHRANE 系统 评价表现了极高热情的杂志。 COCHRANE 协作网对共同出版的基本要求是： COCHRANE 系统评价可以在任何媒体上免费传播，而不用受其杂志约束。 为了保证该条件的实施， COCHRANE 评价者授予 COCHRANE 协作网全球许可证，不与任何杂志或其他出版商签署独家版权所有的协定。 杂志社可要求获得出版和再版系统评价的非独有版权，但不能限制 COCHRANE 协作网以任何适当的形式出版 COCHRANE 系统评价。 ） Reviewers are strongly discouraged from publishing Cochrane Reviews in journals before they are ready for publication in CDSR. This applies particularly to Centre directors and editors of Review Groups. However, journals will sometimes insist that the publication of the review in CDSR should not precede publication in print. When this is the case, reviewers should submit a review for publication in the journal after agreement from their CRG editor and before publication in CDSR. Publication in print should not be subject to lengthy production times, and reviewers should not unduly delay publication of a Cochrane Review either beca。